- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2052-8426
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Gene therapy for malignant glioma ; volume:2 ; number:1 ; day:8 ; month:7 ; year:2014 ; pages:1-19 ; date:12.2014
Molecular and cellular therapies ; 2, Heft 1 (8.7.2014), 1-19, 12.2014
- Urheber
-
Okura, Hidehiro
- Beteiligte Personen und Organisationen
-
Smith, Christian A.
Rutka, James T.
SpringerLink (Online service)
- DOI
-
10.1186/2052-8426-2-21
- URN
-
urn:nbn:de:1111-2016042318479
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:58 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Okura, Hidehiro
- Smith, Christian A.
- Rutka, James T.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Gene therapy of malignant glioma with retroviral vectors and tumorinfiltrating progenitor cells
Gene therapy of malignant glioma with retroviral vectors and tumor-infiltrating progenitor cells
Clinical advances in oncolytic virus therapy for malignant glioma: a systematic review
Lrig1 is a haploinsufficient tumor suppressor gene in malignant glioma
Exploiting tumor-intrinsic signals to induce mesenchymal stem cell-mediated suicide gene therapy to fight malignant glioma
Microenvironmental regulation of tumor-associated neutrophils in malignant glioma: from mechanism to therapy
Metformin as adjuvant therapy for glioma
Palliative care for in-patient malignant glioma patients in Germany
5-Aminolevulinic acid increases boronophenylalanine uptake into glioma stem cells and may sensitize malignant glioma to boron neutron capture therapy
Targeted glioma stem cell depletion through pharmacological WNT inhibition as a novel therapy for malignant brain tumors
In-patient neurosurgical tumor treatments for malignant glioma patients in Germany
Vesicular stomatitis virus (VSV)-based systems for oncolytic virotherapy of malignant glioma
Gene therapy of malignant glioma with retroviral vectors and tumorinfiltrating progenitor cells
Gene therapy of malignant glioma with retroviral vectors and tumor-infiltrating progenitor cells
Clinical advances in oncolytic virus therapy for malignant glioma: a systematic review
Lrig1 is a haploinsufficient tumor suppressor gene in malignant glioma
Exploiting tumor-intrinsic signals to induce mesenchymal stem cell-mediated suicide gene therapy to fight malignant glioma
Microenvironmental regulation of tumor-associated neutrophils in malignant glioma: from mechanism to therapy
Metformin as adjuvant therapy for glioma
Palliative care for in-patient malignant glioma patients in Germany
5-Aminolevulinic acid increases boronophenylalanine uptake into glioma stem cells and may sensitize malignant glioma to boron neutron capture therapy
Targeted glioma stem cell depletion through pharmacological WNT inhibition as a novel therapy for malignant brain tumors
In-patient neurosurgical tumor treatments for malignant glioma patients in Germany
Vesicular stomatitis virus (VSV)-based systems for oncolytic virotherapy of malignant glioma
Gene therapy of malignant glioma with retroviral vectors and tumorinfiltrating progenitor cells
Gene therapy of malignant glioma with retroviral vectors and tumor-infiltrating progenitor cells
Clinical advances in oncolytic virus therapy for malignant glioma: a systematic review
Lrig1 is a haploinsufficient tumor suppressor gene in malignant glioma
Exploiting tumor-intrinsic signals to induce mesenchymal stem cell-mediated suicide gene therapy to fight malignant glioma
Microenvironmental regulation of tumor-associated neutrophils in malignant glioma: from mechanism to therapy
Metformin as adjuvant therapy for glioma
Palliative care for in-patient malignant glioma patients in Germany
5-Aminolevulinic acid increases boronophenylalanine uptake into glioma stem cells and may sensitize malignant glioma to boron neutron capture therapy
Targeted glioma stem cell depletion through pharmacological WNT inhibition as a novel therapy for malignant brain tumors
In-patient neurosurgical tumor treatments for malignant glioma patients in Germany